Assessment of response to treatment in advanced breast cancer. British Breast Group
Lancet 2(7871): 38-39
1974
ISSN/ISBN: 0140-6736 PMID: 4134716 Document Number: 73948
Document emailed within 1 workday
Related Documents
Al-Alwan, N.A.; al-Kubaisy, W.; al-Rawaq, K. 2000: Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer Eastern Mediterranean Health Journal 6(2-3): 475-482Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Axelsson, C.K.; Andersen, J.A.; Andersen, K.W.; Blichert-Toft, M.; Dombernowsky, P.; Hansen, M.; Krag, C.; Mouridsen, H.T.; Overgaard, M.; Rasmussen, B.B. 1991: Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group) Ugeskrift for Laeger 153(33): 2276-2279
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Tominaga, T.; Nomura, Y.; Adachi, I.; Aoyama, H.; Nagao, K.; Mitsuyama, S.; Nakamura, Y.; Ogita, M.; Sano, M.; Takashima, S. 1994: Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 809-816
Rintasyöpäryhmä ry, S. 1997: Recommended treatment guideline for breast cancer. Finnish Breast Cancer Group Duodecim; Laaketieteellinen Aikakauskirja 113(22): 2341-2348
Moore, F.D.; VanDevanter, S.B.; Boyden, C.M.; Lokich, J.; Wilson, R.E. 1974: Adrenalectomy with chemotherapy in the treatment of advanced breast cancer: objective and subjective response rates; duration and quality of life Surgery 76(3): 376-390
Okawa, T.; Ikeda, M.; Mikuriya, S.; Hashimoto, S.; Amino, S.; Horiuchi, J.; Matsuda, T.; Ebata, K.; Kaneda, K. 1985: A clinical study of radiotherapy with HCFU for advanced and recurrent breast cancers. Radiation and HCFU Study Group for breast cancer Gan no Rinsho. Japan Journal of Cancer Clinics 31(2): 131-136
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Stolfi, R.; Parisi, A.M.; Natoli, C.; Iacobelli, S. 1990: Advanced breast cancer: response to somatostatin Anticancer Research 10(1): 203-204
Samal, B.; Jones, S.; Brownlee, R.W.; Morrison, F.; Hoogstraten, B.; Caoili, E.; Baker, L. 1978: Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study Cancer Treatment Reports 62(1): 19-22
Matsui, K.; Tazawa, K.; Karato, M.; Nagata, T.; Shimada, Y.; Tsukada, K. 2010: An elderly advanced breast cancer with a good response to anastrozole Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(8): 1557-1560
Cocconi, G.; De Lisi, V.; Mori, P.; Bozzetti, C. 1982: Estrogen receptors and response to chemotherapy in advanced breast cancer Tumori 68(1): 67-71
Chagpar, A.B. 2007: Insights into the management of locally advanced, inflammatory, and metastatic breast cancer: highlights from the 2007 Louisville Breast Cancer Update Journal of the Kentucky Medical Association 105(11): 559-560
Kiang, D.T.; Frenning, D.H.; Gay, J.; Goldman, A.I.; Kennedy, B.J. 1980: Estrogen receptor status and response to chemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2814-2817
Sledge, G.W.; Robert, N.; Sparano, J.A.; Cogleigh, M.; Goldstein, L.J.; Neuberg, D.; Rowinsky, E.; Baughman, C.; McCaskill-Stevens, W. 1995: Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer Seminars in Oncology 22(3 Suppl 6: 105-108
Lundin, A.C.; Söderkvist, P.; Eriksson, B.; Bergman-Jungeström, M.; Wingren, S. 1999: Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group Cancer Research 59(10): 2332-2334
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325